Search Results - "Melamed‐Gal, Sigal"
-
1
Modafinil and the risk of cardiovascular events: Findings from three US claims databases
Published in Pharmacoepidemiology and drug safety (01-11-2018)“…Purpose This study examined the potential risk of cardiovascular (CV) events associated with modafinil and the consistency of the risk estimates across…”
Get full text
Journal Article -
2
Compositional differences between Copaxone and Glatopa are reflected in altered immunomodulation ex vivo in a mouse model
Published in Annals of the New York Academy of Sciences (01-11-2017)“…Copaxone (glatiramer acetate, GA), a structurally and compositionally complex polypeptide nonbiological drug, is an effective treatment for multiple sclerosis,…”
Get full text
Journal Article -
3
Physicochemical and Biological Examination of Two Glatiramer Acetate Products
Published in Biomedicines (03-07-2019)“…Herein we compared 40 mg/mL lots of the active ingredient, glatiramer acetate, manufactured by Mylan/Natco to the active ingredient, glatiramer acetate in…”
Get full text
Journal Article -
4
Pregnancy outcomes in patients with multiple sclerosis and exposure to branded glatiramer acetate (P4.2-096)
Published in Neurology (09-04-2019)“…Abstract only…”
Get full text
Journal Article -
5
Pregnancy Outcomes in Patients with MS Exposed to Branded Glatiramer Acetate (P1.365)
Published in Neurology (18-04-2017)“…Abstract only…”
Get full text
Journal Article -
6
Pregnancy outcomes in patients with multiple sclerosis and exposure to branded glatiramer acetate during all three trimesters (P4.362)
Published in Neurology (10-04-2018)“…Abstract only…”
Get full text
Journal Article -
7
Real-world switching patterns among US generic glatiramer acetate multiple sclerosis patients (P3.2-099)
Published in Neurology (09-04-2019)“…Abstract only…”
Get full text
Journal Article -
8
Defining Glatiramer Acetate: The USA Definition of Sameness and the EU Definition of Similarity (P3.415)
Published in Neurology (10-04-2018)“…Abstract only…”
Get full text
Journal Article -
9
Physicochemical and Biological Characterization of both Copaxone and the European Follow-On Glatiramer Acetate Product (P1.400)
Published in Neurology (10-04-2018)“…Abstract only…”
Get full text
Journal Article -
10
Integrated Transcriptomic and Physicochemical Characterization of Glatiramer Acetate Products (Copaxone and Glatopa) Available in the United States (P1.370)
Published in Neurology (10-04-2018)“…Abstract only…”
Get full text
Journal Article -
11
Response to the Letter-to-the Editor by Cohen et al. concerning our eNeurologicalSci article, Melamed-Gal, et al. Physicochemical, biological, functional and toxicological characterization of the European follow-on glatiramer acetate product as compared with Copaxone. eNeurologicalSci 2018;12:19–30.https://doi.org/10.1016/j.ensci.2018.05.006
Published in eNeurologicalSci (01-12-2018)Get full text
Journal Article